How do genetics and epigenetics interact to influence the activity of a context-dependent enhancer?
How do genetics and epigenetics interact to influence the activity of a context-dependent enhancer?
批准号:
BB/W017598/1
负责人:
Alasdair MacKenzie
金额:
$74.69万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2023
资助国家:
英国
项目状态:
未结题
起止时间:
2023 至 --
中文摘要
过量摄入乙醇和焦虑等行为对人一生的健康都有重大影响。因此,了解控制乙醇摄入和焦虑的遗传和环境过程,将为开发未来的预防性干预和治疗提供机会。上下文依赖性增强子充当基因开关,负责在特定时间打开和关闭身体特定细胞中的特定基因。这些增强子对健康的重要性及其在疾病中的可能作用已被许多遗传研究(GWAS)所强调,这些研究表明,对我们以健康方式衰老的能力产生负面影响的95%的复杂疾病可归因于增强子等调控序列内的DNA变化。至关重要的是,我们之前发现环境因素,包括饮食脂肪摄入量,也可以通过影响增强子序列的活性来影响下一代的健康寿命。不幸的是,我们对这些基因开关的生物学知之甚少,不知道它们如何受到不同物种的遗传和性别的影响,也不知道饮食如何改变它们的活动,以及它们对酒精摄入和焦虑的影响。我们假设,控制编码神经肽(大脑中产生的已知影响行为的短蛋白)的基因的环境依赖性增强子在遗传、性别和饮食的相互作用中发挥作用,从而影响对健康产生负面影响的行为,如乙醇摄入和焦虑。为了解决这一假设,我们确定了一种增强子(GAL5.1),它在小鼠和人类中几乎保持不变。GAL5.1在大脑的特定细胞中开启一种叫做GAL的神经肽基因,其中GAL控制着乙醇的摄入和焦虑。重要的是,我们发现这种增强子含有与人类男性焦虑和酗酒有关的DNA序列变化(多态性)。此外,我们从小鼠中删除了这种增强子,发现不仅GAL基因(在小鼠中称为GAL)几乎关闭,而且这些小鼠不喝那么多乙醇,雄性也不那么焦虑。这是第一次在小鼠和人类中发现一种高度依赖环境的增强子,可以控制乙醇摄入和焦虑;在一生中对健康产生强烈影响的行为。这种增强剂的确定为我们提供了国际公认的多学科团队(阿伯丁,麦克尤恩,麦肯齐,曼彻斯特;Murgatroyd)有一个独特的机会来确定i)调节对人类健康有严重影响的行为(乙醇摄入和焦虑)的环境依赖性增强子的分子机制,ii)饮食如何与DNA序列变化(多态性)和性别相互作用以影响环境依赖性增强子的活性,并比较其在不同物种(小鼠/人类)中的作用。iii)母体在子宫内的饮食如何影响情境依赖性增强子,从而影响后代的行为。GAL5.1的鉴定及其作为环境依赖增强子的特征,为确定影响增强子活性的分子、遗传和饮食依赖机制提供了前所未有的机会,增强子的活性可能对乙醇摄入、焦虑和我们健康衰老的能力有直接影响
英文摘要
Behaviours such as excess ethanol intake and anxiety have a major impact on people's health across the life-course. Thus, understanding the genetic and environmental processes that control ethanol intake and anxiety, across the generations, will provide opportunities to develop future preventative interventions and treatments. Context-dependant enhancers act as gene switches and are responsible for turning specific genes on and off in specific cells of the body and at specific times. The importance of these enhancers to health, and their possible role in disease, has been highlighted by numerous genetic studies (GWAS) which demonstrate that >95% of complex diseases, that negatively affect our ability to age in a healthy manner, can be attributed to DNA changes within regulatory sequences such as enhancers. Critically, we previously discovered that environmental factors, that can include dietary fat intake, can also impact the health span of the next generation by affecting the activity of enhancer sequences. Unfortunately, we know very little about the biology of these gene switches, how they are affected by genetics and sex in different species or how diet alters their activity, and their effects of ethanol intake and anxiety, through the generations.We hypothesised that context-dependant enhancers which control genes encoding neuropeptides (short proteins produced in the brain and known to influence behavior) play a role in the interaction of genetics, sex and diet to influence behaviours that negatively impact the health-span such as ethanol intake and anxiety. To address this hypothesis, we identified an enhancer (GAL5.1) that has remained almost unchanged in both mice and humans. GAL5.1 turns on a neuropeptide gene called GAL in specific cells of the brain where GAL controls ethanol intake and anxiety. Importantly we found that this enhancer contained DNA sequence changes (polymorphisms) that had been associated with anxiety and alcohol abuse in human males. Moreover, we deleted this enhancer from mice and found that, not only was the GAL gene (called Gal in mice) nearly turned off, but that these mice didn't drink as much ethanol and males did not suffer as much anxiety. This is the first time that a highly context-dependent enhancer has been identified in both mice and humans that controls ethanol intake and anxiety; behaviours with a strong impact on health through the life course. Identification of this enhancer provides our internationally recognised multidiscipline team (Aberdeen; McEwan, MacKenzie, Manchester; Murgatroyd) with a unique opportunity to identify i) The molecular mechanisms regulating a context-dependent enhancer which regulates behaviours (ethanol intake and anxiety) with a serious impact on human health, ii) How diet interacts with DNA sequence changes (polymorphisms) and sex to affect the activity of a context-dependant enhancer and compare the effects in different species(Mouse/human).iii) How a context-dependant enhancer is affected by maternal diet in the womb to impact the behaviour of subsequent generations. Identification of GAL5.1, and its characterisation as a context-dependent enhancer, provides an unparalleled opportunity to determine the molecular, genetic and dietary dependent mechanisms influencing the activity of an enhancer whose activity may have a direct impact on ethanol intake and anxiety and our ability to age healthily
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Determining the effects of genetic variation and early life stress on the regulation of the galanin gene in fat and alcohol selection.
-
批准号:BB/N017544/1
-
项目类别:Research Grant
-
资助金额:$53.38万
-
财政年份:2016
-
负责人:Alasdair MacKenzie
-
依托单位:
Prediction and analysis of a regulatory SNP map of Major Depressive Disorder
-
批准号:G0701003/1
-
项目类别:Research Grant
-
资助金额:$128.37万
-
财政年份:2008
-
负责人:Alasdair MacKenzie
-
依托单位:
A computer array approach to accelerating the functional prediction of biological systems
-
批准号:BB/D524932/1
-
项目类别:Research Grant
-
资助金额:$5.59万
-
财政年份:2006
-
负责人:Alasdair MacKenzie
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Janus磁性微纳马达头部尾部功能单元的精细调控实现低PMS浓度触发DO活化形成自由基(SO4•-和•OH)与非自由基(1O2)
-
批准号:52572315
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2025
-
负责人:李嘉
-
依托单位:
复合菌剂在高DO下的好氧反硝化脱氮机制及工艺调控研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:周月明
-
依托单位:
铁皮石斛响应内生真菌DO14效应因子的DcMYB6/9调控葡甘聚糖合成的分子机制
-
批准号:32470403
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2024
-
负责人:吴令上
-
依托单位:
内生真菌DO14多糖PPF30调控铁皮石斛葡甘聚糖生物合成的机制
-
批准号:LZ23H280001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:吴令上
-
依托单位:
基于捕获“Do not eat me”信号的肺癌异质性分子功能可视化及机理研究
-
批准号:92259102
-
项目类别:重大研究计划
-
资助金额:60.00万元
-
批准年份:2022
-
负责人:许川
-
依托单位:
基于达文波特星形酵母Do18强化发酵的糟带鱼生物胺生物调控机制
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:涂传海
-
依托单位:
基于PO-DGT原理的沉积物微界面pH-DO-磷-重金属的精细化同步成像技术研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:54万元
-
批准年份:2022
-
负责人:韩超
-
依托单位:
CD38/cADPR信号通路异常促逼尿肌过度活动(DO)发生的分子机制及干预措施研究
-
批准号:81770762
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2017
-
负责人:郑霁
-
依托单位:
USP2介导RagA去泛素化稳定肿瘤细胞“Do not eat me”信号的机制研究
-
批准号:81773040
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2017
-
负责人:金国祥
-
依托单位:
抑制骨细胞来源Sclerostin蛋白对颌面部DO成骨的协同促进作用
-
批准号:81771104
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2017
-
负责人:钱玉芬
-
依托单位: